Soluble interleukin 2 receptors in patients with polymyositis/dermatomyositis.
AUTOR(ES)
Tokano, Y
RESUMO
The concentration of soluble interleukin 2 receptor was determined in serum samples from 19 patients with polymyositis/dermatomyositis by an enzyme linked immunosorbent assay (ELISA). The concentration of soluble interleukin 2 receptor in serum samples from patients with polymyositis/dermatomyositis was higher than that in samples from normal subjects.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1004746Documentos Relacionados
- Polymyositis/dermatomyositis: the current position.
- Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients.
- Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases.
- Serum myoglobin and creatine kinase concentrations in patients with polymyositis or dermatomyositis.
- Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis
